Novel Cancer Therapeutics Summit 2016

We invite you to attend the 2016 Novel Cancer Therapeutics Summit, to be held on November 7-9, 2016 in San Francisco, CA. This summit includes four parallel conferences focused on both the research, and business perspectives in oncology.

 

This summit will continue to be a premier event for translational researchers, preclinical scientists and managers, and those carrying out early phase clinical trials working to identify and exploit advances in the field of oncology in order to deliver products with a meaningful clinical impact. In addition, industry leaders from big pharma and various biotech/pharmaceutical companies, including business/corporate development executives, licensing executives, global alliance, and venture capitalists, will all be present to explore potential collaborations and learn about relevant issues in oncology.

 

Focus areas include cancer diagnostics, cancer immunotherapy, cancer epigenetics, as well as partnering and deal-making in oncology. Discussion topics include emerging targets, therapeutic strategies, epigenetic targets and tools/technologies, next generation sequencing in cancer diagnosis, progress in cancer immunotherapy, combination strategies in immuno-oncology, advancements in technology, as well as business development trends, markets, partnership opportunities, and access to capital market.

 

Both cutting-edge researchers and those who guide its commercial development will be on-hand to share their knowledge and insights as to how therapeutic cancer targets are identified, and how this research translates into meaningful therapeutics that benefit patients living with cancer!

Sign up for the Summit Pass to have access to all five conferences of the summit!

We hope to see you there!

POSTER SUBMISSIONS:
GTCbio encourages attendees to gain exposure by presenting their work in the poster sessions. Your research will be seen by leaders from top pharmaceutical, biotech, academic and government institutions, and will also be published in the conference materials. The top 2-3 qualified submitted abstracts will also be selected by the meeting's scientific advisory board for the chance to give a short oral presentation in the conference program.

Abstracts are not being selected for the summit. Please submit your abstract for an individual conference.
Click here(https://www.gtcbio.com/submit-an-abstract/cancer-epigenetics) to submit an abstract to our 5th Cancer Epigenetics
Click here(https://www.gtcbio.com/submit-an-abstract/oncology-partnering-deal-making) to submit an abstract to our 5th Oncology Partnering & Deal-Making
Click here(https://www.gtcbio.com/submit-an-abstract/cancer-diagnostics) to submit an abstract to our 2nd Cancer Diagnostics
Click here(https://www.gtcbio.com/submit-an-abstract/cancer-immunotherapy) to submit an abstract to our Cancer Immunotherapy

Deadline to submit abstracts for poster presentations: October 7, 2016
Click here (https://www.gtcbio.com/submit-an-abstract/cancer-therapeutics-summit) to submit an abstract.Complete all fields. Maximum number of words is 250 and maximum number of characters is 2,500. If possible, attach a document (.doc, .docx, or .pdf) should your abstract exceed the maximum number of words.

Deadline to register and secure your poster board slot: October 24, 2016
Please note that submitting your abstract does NOT guarantee you a poster board at the meeting. GTCbio reserves poster boards based on the number of delegates whose abstracts have been approved and have registered and paid in full for the conference. Any abstracts submitted after the registration deadline will not be guaranteed a poster board.
Important Notes:

1. You will be notified by the conference organizers via email as soon as your submission has been reviewed.
2. Posters accepted by the deadline will be considered for oral presentation one month prior to the conference.
3. Posters submitted after the deadline will be considered for poster presentation only.
4. Oral presentation winners will be notified via email or telephone 2-3 weeks before the conference.
5. Selected oral presenters will be posted on the agenda.
6. You must be registered for the conference to present at the poster session.
7. Conference program posters must be relevant to the main conference topics.
POSTER SIZE AND SET UP:
Poster boards are 4 feet in width by 6 feet in height. (122 cm by 182 cm). Posters should be portrait orientation, with maximum dimensions to fit on the board accordingly. If accepted for the poster session, an email will be sent with details on when and where to pin your poster. Pins will be provided.
* GTCbio reserves the right to publish your poster title and abstract in various marketing materials and products.
ABOUT GTCBIO

GTCbio is a leading information center that provides quality forums, which facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic and government organizations, and the financial community. Our conferences cover a variety of topics, such as stem cell therapeutics, infectious diseases, biotech partnering, pharmaceutical litigation, government regulation, bio-based chemicals and many more. Founded in 2002, GTCbio stimulates scientific discussions, offers key business insights, and promotes partnering and deal-making in the ever-changing biotech and pharmaceutical world.

Others Details

visit: https://www.gtcbio.com/conferences/cancer-therapeutics-summit-overview